Professional Seasonal Analysis for Trading

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

Seasonality Analysis

Stocks 6 Years Analyzed

Tarsus Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

44.79%
Avg Annual Return
52.5%
Avg Monthly Win Rate
7/12
Positive Months
6
Years Analyzed

Tarsus Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -0.90%
33%
Very Weak
February 1.18%
33%
Weak
March -5.50%
17%
Very Weak
April 2.41%
67%
Strong
May -0.10%
60%
Weak
June WORST -6.04%
40%
Weak
July -2.39%
20%
Very Weak
August 14.71%
80%
Very Strong
September 5.97%
80%
Very Strong
October 12.54%
67%
Strong
November 6.52%
67%
Strong
December BEST 16.39%
67%
Strong

Tarsus Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
55.13
Historical Avg Position
30.78
Deviation
+24.35
Performance
Significantly Above Average

Tarsus Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for TARS with overlay patterns, custom date ranges, and more.

Create Free Account

Tarsus Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Tarsus Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for TARS across multiple timeframes.

Create Free Account

About Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) Seasonality

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) has been analyzed using 6 years of historical data to identify seasonal patterns. Classified under Stocks, Tarsus Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Tarsus Pharmaceuticals, Inc. - Common Stock is historically December, with an average return of 16.39% and a win rate of 67%. Conversely, June tends to be the weakest month, averaging -6.04% return.

Looking at the full calendar year, Tarsus Pharmaceuticals, Inc. - Common Stock has an average annual return of 44.79% with an overall monthly win rate of 52.5%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Tarsus Pharmaceuticals, Inc. - Common Stock has a consistency score of 61.5 (Good), based on 7 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Tarsus Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)?

Historically, December has been the best month for Tarsus Pharmaceuticals, Inc. - Common Stock, with an average return of 16.39% and a win rate of 67%. However, past performance does not guarantee future results.

What is the worst month for Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)?

Based on historical data, June has been the weakest month for Tarsus Pharmaceuticals, Inc. - Common Stock, with an average return of -6.04%. This is a historical observation and does not guarantee future results.

How reliable is TARS seasonality data?

The seasonality analysis for Tarsus Pharmaceuticals, Inc. - Common Stock is based on 6 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Tarsus Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.